Q4-FY26 · Q3 FY26
FY27 Revenue Target: Cross 1,000 crores
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
missed
heuristic_v1
MOLDTEKPACKAGING / Q4-FY26 / promises
Measure what management said.
Mold Tek Packaging · A quarter-by-quarter view of forward statements and whether delivery is visible yet.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Management delivery ledger
Promises over time.
Q4-FY26 · Q3 FY26
Pharma Revenue: 50-55 crores in FY27
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
missed
heuristic_v1
Q4-FY26 · Q3 FY26
FY27 Capex: 80-85 crores (down from 120 crores)
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
missed
heuristic_v1
Q4-FY26 · Q3 FY26
EBITDA FY27: Comfortably above 200 crores
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
missed
heuristic_v1